Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119416 · ClinicalTrials.gov registry record · NA
Gender Difference in Response to Caffeine in Children and Adolescents
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT02119416 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 101 participants.
The verdict
NCT02119416, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
Caffeine use is on the rise in America, and one of the most popular sources is soda. Among youth ages 8-16, caffeine consumption has increased by over 70% in the past 30 years. Few studies have examined the role of hormones in caffeine consumption within this age group. The purpose of the current experiment was to determine the effect of caffeine on children 8 and 9 compared to those 15 and 16 years of age. The investigators were looking at the effect of puberty on the consumption of caffeine as well as the effect that the caffeine has on the body (for example: heart rate, blood pressure) and cognitive function.
Interventions
- DRUG Placebo Administration first
- DRUG Low Caffeine Administration first (1mg/kg body weight)
- DRUG High Caffeine Administration first (2mg/kg body weight)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02119416
The ClinicalTrials.gov registry entry for NCT02119416 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo Administration first is the first listed.
NCT02119416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02119416 about?
NCT02119416 is a clinical study titled "Gender Difference in Response to Caffeine in Children and Adolescents". Caffeine use is on the rise in America, and one of the most popular sources is soda. Among youth ages 8-16, caffeine consumption has increased by over 70% in the past 30 years. Few studies have examined the role of hormones in caffeine consumption within this age group. The purpose of the current e...
What is the current status of trial NCT02119416?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2011-08. Estimated completion is 2012-10.
What interventions are being tested in trial NCT02119416?
The interventions under investigation include: Placebo Administration first (DRUG), Low Caffeine Administration first (1mg/kg body weight) (DRUG), High Caffeine Administration first (2mg/kg body weight) (DRUG).
Who is sponsoring clinical trial NCT02119416?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.